Skip to content
Recall Observatory FDA recall evidence

Drug product

Glycopyrrolate Tablets, USP 1 mg, 100-count bottle, Rx only, Dist. by: Par Pharmaceutical, Chestnut Ridge, NY, 10977, U.S.A, Mfg. by: Par Formulations Private Limited, 1/58, Pudupakkam, Kelambakkam - 603 103., Made in India NDC# 49884-0065-01

D-1071-2020

March 30, 2020

Class II

Product summary

Firm
Par Pharmaceutical Inc.
Event
Event 85333
Status
Terminated
Classification
Class II
Quantity
29,352 bottles
Official record key
drug-enforcement:D-1071-2020

Official wording

Reason: Failed Impurities/Degradation Specification: Presence of unknown impurity observed.

Code information: Lot # 32809101, Exp 3/2021

Distribution pattern: Product was distributed within the United States.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specification